{"title":"Dabrafenib and trametinib-induced hyperglycemia with decreased insulin secretion in a patient with lung adenocarcinoma.","authors":"Kohei Nagano, Masaki Suzuki, Saki Morikawa, Rikiya Watanabe, Takeshi Ohara, Kenta Hara","doi":"10.1210/jcemcr/luag256","DOIUrl":"10.1210/jcemcr/luag256","url":null,"abstract":"<p><p>Hyperglycemia is an adverse effect of targeted cancer therapies; however, the mechanisms underlying B-Raf proto-oncogene, serine/threonine kinase (BRAF)/mitogen-activated protein kinase kinase (MEK) inhibitor-associated hyperglycemia remain unclear. We describe an 80-year-old man who developed severe hyperglycemia during combination therapy with dabrafenib and trametinib for <i>BRAF</i> V600E-positive lung adenocarcinoma. Before treatment, he was obese and had unrecognized mild diabetes. Seven months after treatment initiation, he presented with hyperglycemia accompanied by a reduced insulin secretory capacity. Serial measurements of the C-peptide index revealed that the temporary withdrawal of dabrafenib-trametinib resulted in the recovery of insulin secretion, which gradually decreased again upon reinitiation. This case underscores the clinical importance of monitoring both the glycemic status and insulin secretion in patients receiving BRAF/MEK inhibitors.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"4 9","pages":"luag256"},"PeriodicalIF":0.0,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13538961/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148889611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JCEM case reportsPub Date : 2026-09-03eCollection Date: 2026-09-01DOI: 10.1210/jcemcr/luag246
Sandra Gad, Nima Kokabi, Michael Mohnasky, Ralph P Tufano, Juan C Camacho
{"title":"Complete pathologic necrosis of a thyroid neoplasm following pressure-enabled thyroid artery embolization.","authors":"Sandra Gad, Nima Kokabi, Michael Mohnasky, Ralph P Tufano, Juan C Camacho","doi":"10.1210/jcemcr/luag246","DOIUrl":"10.1210/jcemcr/luag246","url":null,"abstract":"<p><p>Thyroid nodules are increasingly detected with advanced imaging. Although most are benign, accurate preoperative risk stratification remains essential. Fine-needle aspiration is central to evaluation, yet Bethesda III nodules remain challenging because of the variable malignancy risk. Thyroid carcinoma generally has a favorable prognosis, but certain molecular subtypes are associated with higher mortality. Therefore, surgical resection remains the standard treatment for indeterminate and malignant thyroid tumors. However, the thyroid's rich vascular supply, along with comorbidities and factors such as age and mediastinal extension, can increase operative risk. Preoperative transarterial embolization has emerged as an adjunct to reduce tumor vascularity and improve surgical outcomes. We report a case of a 72-year-old African American male with multiple comorbidities who presented with an indeterminate thyroid neoplasm harboring a <i>TERT</i> promoter pathogenic variant, indicating high malignancy risk. The patient underwent pressure-enabled thyroid artery embolization followed by thyroidectomy 72 hours postembolization. Lesion histopathology showed nuclear debris and ghost cells consistent with complete pathologic necrosis. This case supports the feasibility of embolization as an adjunct in the multidisciplinary management of high-risk patients and provides a foundational basis to further study embolotherapy in unresectable tumors or nonsurgical candidates.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"4 9","pages":"luag246"},"PeriodicalIF":0.0,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13538960/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148889647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JCEM case reportsPub Date : 2026-09-03eCollection Date: 2026-09-01DOI: 10.1210/jcemcr/luag252
Kaho Kiuchi, Chieko Kusano, Naoaki Hori, Satoshi Narumi, Tomonobu Hasegawa
{"title":"Dual ectopic thyroid located at the tongue base and left parapharyngeal space with transient congenital hypothyroidism.","authors":"Kaho Kiuchi, Chieko Kusano, Naoaki Hori, Satoshi Narumi, Tomonobu Hasegawa","doi":"10.1210/jcemcr/luag252","DOIUrl":"10.1210/jcemcr/luag252","url":null,"abstract":"<p><p>Ectopic thyroid is a rare developmental anomaly. In ectopic thyroid, thyroid tissue develops outside its normal position (anterior to the trachea), and it can occur within or outside the migratory pathway of the thyroid gland primordium. Ectopic thyroid tissue located in two sites is referred to as dual ectopic thyroid. This report describes a case of transient congenital hypothyroidism (CH) who had dual ectopic thyroid glands: one located at the base of the tongue (within the migratory pathway) and the other in the left parapharyngeal space (outside the migratory pathway). A 24-year-old woman, diagnosed with CH in the neonatal period, had been treated with levothyroxine. Since levothyroxine was discontinued at the age of 7 years, her thyroid function has remained normal. At 24 years of age, she was reevaluated because of throat discomfort. Although her thyroid function remained normal, ultrasonography revealed two ectopic thyroid masses. <sup>99m</sup>Tc thyroid scintigraphy confirmed thyroid tissue in both locations. Genetic analysis did not reveal any suspicious genetic changes related to CH. Currently, she is under observation without treatment. This rare case of dual ectopic thyroid with transient CH underscores the importance of anatomical evaluation and long-term follow-up in patients with neonatal thyroid disorders.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"4 9","pages":"luag252"},"PeriodicalIF":0.0,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13538962/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148889656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JCEM case reportsPub Date : 2026-08-31eCollection Date: 2026-09-01DOI: 10.1210/jcemcr/luag245
Sandro La Vignera, Rosita A Condorelli
{"title":"Tirzepatide non-response with subsequent semaglutide response in class 2 obesity.","authors":"Sandro La Vignera, Rosita A Condorelli","doi":"10.1210/jcemcr/luag245","DOIUrl":"10.1210/jcemcr/luag245","url":null,"abstract":"<p><p>We report a paradoxical case of a 40-year-old man with class 2 obesity (body mass index 39.8 kg/m<sup>2</sup>) and insulin resistance (homeostatic model assessment of insulin resistance [HOMA-IR] 5.0; reference <2.0) who achieved minimal weight loss (<5%) despite tirzepatide dose escalation to 15 mg weekly over 6 months. Following switch to semaglutide 2.4 mg weekly, the patient achieved 20% weight loss over 6 months, with normalization of fasting glucose, resolution of insulin resistance, and marked improvement in appetite control. This case challenges the assumption that dual glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 (GLP-1) receptor agonism is universally superior to selective GLP-1 receptor agonism for weight management. Mechanistic analysis suggests that adipose tissue GIP receptor downregulation in the context of class 2 obesity and insulin resistance, combined with intact central GLP-1 receptor signaling, may explain the differential response in some individuals. Key learning points include: markedly elevated baseline insulin resistance (HOMA-IR ≥4-5) may be associated with poor tirzepatide response, though prospective validation is required; persistent hyperphagia during tirzepatide treatment is an early warning sign; and nonresponse to tirzepatide does not preclude semaglutide response. This case supports precision medicine approaches in obesity pharmacotherapy, including pretreatment phenotyping and early response assessment.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"4 9","pages":"luag245"},"PeriodicalIF":0.0,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13526503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148868271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Delayed diagnosis of acromegaly when lower facial features were obscured by masks during the COVID-19 pandemic.","authors":"Taka-Aki Sakaue, Kosuke Mukai, Yuki Kajimoto, Yoshinari Obata, Mitsuyoshi Takahara, Iichiro Shimomura","doi":"10.1210/jcemcr/luag163","DOIUrl":"10.1210/jcemcr/luag163","url":null,"abstract":"<p><p>Acromegaly, caused by excessive growth hormone secretion from a pituitary tumor, is associated with characteristic acral changes and multiple comorbidities. Changes in physical appearance, particularly involving the face and extremities, are the most common triggers for the diagnosis of acromegaly. Since the COVID-19 pandemic, widespread mask wearing in medical settings may interfere with the recognition of acromegaly by obscuring key facial features such as the lips and nose. We report the case of a 74-year-old woman referred for poorly controlled diabetes mellitus (DM). She exhibited disproportionate insulin resistance and excessive insulin secretion despite the absence of obesity or visceral fat accumulation. These metabolic abnormalities prompted further physical examination, which revealed characteristic facial changes that had previously been concealed by mask wearing, ultimately leading to the diagnosis of acromegaly. This case highlights that while mask use is essential for infection control, it may inadvertently delay recognition of acromegaly. Clinicians should therefore remain vigilant and carefully evaluate facial features, particularly in patients with conditions commonly associated with acromegaly, such as DM and hypertension. These findings also underscore the importance of careful facial examination in future pandemics or public health emergencies requiring widespread mask use.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"4 9","pages":"luag163"},"PeriodicalIF":0.0,"publicationDate":"2026-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13522841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148851134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tumor-specific <i>KCNJ5</i> mutation in an aldosterone-producing adenoma not detected in adrenal venous plasma cell-free DNA.","authors":"Daisuke Aono, Toshiaki Kato, Mitsuhiro Kometani, Takashi Yoneda, Kazuyoshi Hosomichi, Shigehiro Karashima","doi":"10.1210/jcemcr/luag222","DOIUrl":"10.1210/jcemcr/luag222","url":null,"abstract":"<p><p>Circulating tumor DNA (ctDNA) can be detected in adrenocortical carcinoma; however, its detectability in benign adrenal tumors, such as aldosterone-producing adenoma (APA), remains unclear. We investigated whether tumor-specific mutations could be detected in plasma cell-free DNA (cfDNA) obtained from peripheral and adrenal venous blood in a 34-year-old man with APA. The patient was evaluated for secondary hypertension, and screening and confirmatory tests established the diagnosis of primary aldosteronism. Computed tomography revealed an 11-mm left adrenal mass, and adrenal venous sampling demonstrated left-sided aldosterone hypersecretion. The patient subsequently underwent left adrenalectomy, and pathological examination confirmed an APA. Targeted next-generation sequencing of 18 adrenal disease-related genes identified a somatic <i>KCNJ5</i> mutation in the tumor tissue. However, the corresponding mutation was not detectable in cfDNA from either peripheral or adrenal venous plasma, despite sampling under clinically favorable conditions. Postoperatively, blood pressure and serum potassium levels normalized. This case illustrates the challenges of detecting tumor-derived mutations in plasma from small benign adrenal tumors using standard sequencing approaches and highlights how tumor burden, sampling conditions, and assay sensitivity influence ctDNA detectability. Further studies employing highly sensitive, mutation-targeted methods are warranted to elucidate the biological and technical factors affecting ctDNA detection in APA.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"4 9","pages":"luag222"},"PeriodicalIF":0.0,"publicationDate":"2026-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13522837/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148851187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JCEM case reportsPub Date : 2026-07-27eCollection Date: 2026-08-01DOI: 10.1210/jcemcr/luag199
Thirza van der Linden, Bjorn Dumont, Yalin Acardag, Johannes Hofland, Sjoerd Thijsse, Charlotte van Noord
{"title":"Cardiogenic shock due to pheochromocytoma-induced catecholamine crisis in a young woman.","authors":"Thirza van der Linden, Bjorn Dumont, Yalin Acardag, Johannes Hofland, Sjoerd Thijsse, Charlotte van Noord","doi":"10.1210/jcemcr/luag199","DOIUrl":"10.1210/jcemcr/luag199","url":null,"abstract":"<p><p>A pheochromocytoma is a rare catecholamine-secreting tumor that can cause life-threatening complications. Circulatory shock with a significant cardiogenic component is an uncommon initial presentation. This case describes a previously healthy 30-year-old woman presenting with vomiting, hyperglycemia, and shock. This rapidly progressed to requiring intubation, vasopressor therapy, and resuscitation following cardiac arrest. Imaging revealed a right adrenal mass and plasma metanephrines and normetanephrines were markedly elevated. After stabilization with α- and β-adrenergic blockade, the patient underwent successful adrenalectomy, confirming a pheochromocytoma-induced catecholamine crisis, with full recovery of cardiac function. This case illustrates the diversity of initial presentation of pheochromocytoma, the diagnostic challenges associated with measuring plasma (nor)metanephrines after resuscitation and the reversible nature of catecholamine-induced cardiomyopathy.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"4 8","pages":"luag199"},"PeriodicalIF":0.0,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13402045/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148594886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JCEM case reportsPub Date : 2026-07-27eCollection Date: 2026-08-01DOI: 10.1210/jcemcr/luag195
Lizanne Berkenbosch, Saartje Straetemans
{"title":"A challenging diagnosis of pediatric (cyclic) Cushing disease: the decisive role of hair cortisol.","authors":"Lizanne Berkenbosch, Saartje Straetemans","doi":"10.1210/jcemcr/luag195","DOIUrl":"10.1210/jcemcr/luag195","url":null,"abstract":"<p><p>Cushing disease is a rare and often difficult diagnosis. Therefore, a significant delay between the onset of symptoms and the final diagnosis frequently occurs. We present a previously healthy 12-year-old boy in whom hypercortisolism was suspected based on clinical symptoms: abrupt excessive weight gain despite adequate exercise and dietary interventions in combination with growth arrest. The results of conventional biochemical diagnostics for Cushing disease were contradicting and could not confirm the diagnosis. Because of a persistent clinical suspicion after a wait-and-see period, cortisol levels in the boy's 11 cm long hair were analyzed. The very high hair cortisol levels supported the clinically suspected Cushing disease. Magnetic resonance imaging of the pituitary showed evidence of an adenoma, which was confirmed postoperatively as an adrenocorticotropic hormone producing adenoma. This confirmed the diagnosis of Cushing disease, with most likely a cyclical course, 1.5 years after the initial presentation. This case adds to the scarce literature on pediatric cyclic Cushing disease and emphasizes the added value of hair cortisol.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"4 8","pages":"luag195"},"PeriodicalIF":0.0,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13402041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148594869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JCEM case reportsPub Date : 2026-07-27eCollection Date: 2026-08-01DOI: 10.1210/jcemcr/luag203
Pedro Arthur da Rocha Ribas, Guilherme Martins, Cleo Otaviano Mesa Junior, Gisah Amaral, Fabíola Yukiko Miasaki
{"title":"Thyroid storm triggered by perianal abscess: clinical overlap with severe thyrotoxicosis.","authors":"Pedro Arthur da Rocha Ribas, Guilherme Martins, Cleo Otaviano Mesa Junior, Gisah Amaral, Fabíola Yukiko Miasaki","doi":"10.1210/jcemcr/luag203","DOIUrl":"10.1210/jcemcr/luag203","url":null,"abstract":"<p><p>Thyroid storm is a rare and potentially fatal endocrine emergency, most commonly precipitated by infections, withdrawal of antithyroid drugs, or acute events in patients with Graves disease. Reports associated with thyroiditis or with unusual infections, such as perianal abscess, are exceptionally uncommon. We describe the case of a 61-year-old previously healthy man admitted with a perianal abscess complicated by atrial fibrillation with rapid ventricular response and thyroid storm. The patient received intensive treatment with propylthiouracil, Lugol solution, propranolol, corticosteroids, antibiotics, and electrical cardioversion, resulting in sustained reversion to sinus rhythm. During follow-up, he developed permanent hypothyroidism, requiring levothyroxine replacement. Beyond the perianal infection as an evident trigger, the progression to definitive hypothyroidism and positive antithyroid peroxidase antibodies also raises the uncommon possibility of hashitoxicosis as the underlying etiology. This case illustrates an atypical presentation of thyroid storm, underscoring the importance of early recognition and multidisciplinary management.</p>","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"4 8","pages":"luag203"},"PeriodicalIF":0.0,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13402044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148594872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JCEM case reportsPub Date : 2026-07-27eCollection Date: 2026-08-01DOI: 10.1210/jcemcr/luag202
Antony Fu
{"title":"Beyond a single diagnosis: coexisting <i>PAPSS2</i> brachyolmia and growth hormone deficiency in a child with short stature.","authors":"Antony Fu","doi":"10.1210/jcemcr/luag202","DOIUrl":"10.1210/jcemcr/luag202","url":null,"abstract":"","PeriodicalId":73540,"journal":{"name":"JCEM case reports","volume":"4 8","pages":"luag202"},"PeriodicalIF":0.0,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13402040/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148594895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}